Are you an insurance policyholder in India wondering about the exact terms and conditions of the policies you hold? Many citizens find themselves in a similar situation, seeking clarity on the approved details of insurance products. This case highlights how the Right to Information (RTI) Act can be a powerful tool to demand transparency from regulatory bodies and ensure that vital information is accessible to the public. Understanding this case can empower you to seek similar information and hold authorities accountable.
Background: What Information Was Sought
The RTI applicant in this case wanted to obtain details of insurance policies that General Insurance Companies had filed and got approved under the ‘file and use’ policy or regulation. This policy, permitted Insurance Regulatory and Development Authority (IRDA), allows general insurance companies to circulate their products in India. Essentially, the applicant sought access to the approved terms and conditions of these insurance products to ensure transparency in the market.
How the Public Authority Responded
The Public Information Officer (PIO) of the IRDA initially responded that the requested information was already available on the Public Authority’s website. However, the applicant argued that simply stating the information is online is not enough if it’s not easily accessible or if the full details of approved products are not readily published. The applicant contended that it was the IRDA’s obligation to proactively publish the complete terms and conditions of all approved insurance products on its website immediately after granting clearance to insurers. The absence of such transparency, the applicant argued, allowed insurance companies to potentially alter clauses in the final marketed products, leaving policyholders unaware of the original approved terms.
The PIO further explained the sheer volume of information involved. Since 2001, approximately 500 tariff products had been approved Tariff Advisory Committee, and around 1500 non-tariff products were marketed of India and 25-26 general insurance companies. While the PIO indicated that uploading details of tariff products might be feasible within 4 to 6 weeks, the task of uploading non-tariff products was acknowledged as a huge undertaking. Crucially, the PIO raised a concern under Section 8(1)(d) of the RTI Act, arguing that disclosing the terms and conditions of insurance policies filed with the Authority could harm the competitive position of third-party insurance companies, and thus, was exempt from disclosure.
The CIC Hearing: What Happened
The matter reached the Central Information Commission (CIC). The CIC examined the arguments presented the applicant and the PIO. The CIC did not accept the PIO’s contention that the information was sufficiently available on the insurers’ own websites. The Commission emphasized that the responsibility lay with the regulatory authority to ensure public accessibility of such crucial information. The CIC underscored that the matter was of “overwhelming larger public interest” and demanded “complete and total transparency.” The Commission found that the argument of potential harm to competitive positions, as cited under Section 8(1)(d), was not a sufficient reason to withhold information of such significant public importance.
The CIC Order and Its Significance
The CIC, invoking its powers under Section 19(8)(a)(iii) and Section 19(8)(a)(iv), along with Section 25(5) of the RTI Act, made a significant recommendation. It directed the Chairman of the IRDA to take appropriate action to publish the complete and full terms and conditions of all insurance products that had been approved on the regulator’s website. The Commission clarified that only the approved insurance products’ details should be disclosed. Furthermore, the CIC permitted the IRDA to use Section 10 of the RTI Act to redact or withhold specific parts of the information if they genuinely believed that disclosing certain details related to any particular approved insurance product would indeed hurt commercial confidence, trade secrets, or intellectual property, leading to harm to the competitive position of any insurance company. This provision allows for partial disclosure.
Key Lessons for RTI Applicants
- Lesson 1: Public Interest Trumps Commercial Concerns: This case demonstrates that when information is of significant public interest, the argument of commercial confidentiality under Section 8(1)(d) might not hold strong grounds for denial if larger public interest warrants disclosure. Your RTI applications should clearly articulate why the information you seek is in the public interest.
- Lesson 2: Transparency is a Regulatory Duty: Regulatory bodies have a responsibility to ensure that information related to products they approve is accessible to the public. Don’t accept vague responses; push for clear and accessible information.
- Lesson 3: CIC Can Direct Proactive Disclosure: The CIC has the power to direct public authorities to proactively publish information on their websites, especially when it concerns public interest. This case sets a precedent for demanding such proactive disclosure.
How to File a Similar RTI Application
- Identify the Correct Public Authority: Determine the specific regulatory body responsible for approving the type of product or service you are interested in (e.g., IRDA for insurance, SEBI for securities, etc.).
- Clearly State Your Request: Be precise in what information you are seeking. Mention the specific type of products, the approval process, and the desired details (e.g., terms and conditions, approval dates).
- Justify the Public Interest: Explain why the information is important for the public. Highlight potential issues like lack of transparency, policyholder rights, or market fairness.
- Be Prepared for Appeals: If your initial application is denied or you receive an unsatisfactory response, be ready to file a First Appeal and subsequently a Second Appeal to the CIC.
Sample RTI question you can use:
Under Section 4(2) of the RTI Act, 2005, please provide the complete and full terms and conditions of all insurance products approved IRDA for circulation in India, including both tariff and non-tariff products, for the period from [start date] to [end date]. Kindly also provide the date of approval for each product and the names of the insurance companies that filed them. If any information is being withheld under Section 8(1)(d), please provide a detailed justification for each instance and the specific provisions under Section 10 of the RTI Act that are being invoked.
Conclusion
This landmark RTI case underscores the power of the Act in fostering transparency and accountability. your rights and how to effectively use the RTI Act, you can access crucial information about various products and services that impact your life. The CIC’s decision reinforces the principle that transparency in regulated sectors is not just desirable but a fundamental right of citizens. Empower yourself with knowledge and use RTI to ensure a more informed and equitable society.
